Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)
NCT ID: NCT05501613
Last Updated: 2023-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
65 participants
OBSERVATIONAL
2015-01-31
2023-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multimodal Brain Monitoring as a Prognostic Tool for Intracerebral Hemorrhage
NCT05771662
Quality Improvement Initiative for Enhancing Early Mobilization in Intracerebral Hemorrhage Patients
NCT06811350
Neurological Outcomes of Primary Intracerebral Haemorrhage
NCT03995940
Longitudinal Cohort Study on ICH Care
NCT03183167
Prognosis in Intracerebral Hemorrhage. The ICHCat Score in Primary Care.
NCT03247049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multimodal Neuromonitoring
Invasive Multimodal Neuromonitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ICU admission
* Need of Sedation and Ventilatory Support
* Need of Intracerebral Neuromonitoring
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade do Porto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana Filipa Vaz Ferreira
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Hospitalar Universitário de São João
Porto, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.